EULAR data demonstrated potential for immune reset, including remissions, in both systemic lupus erythematosus (SLE) and ...

A Cambridge biotech company is laying off 85% of staff and ending its sickle cell drug after the FDA cited unacceptable ...

Agreement offers potential best-in-class targeted protein degrader therapy option for people living with B-cell ...

Patients on the trial have not needed medication to manage their condition.

The new facility will boost US solar cell production, as well as create 400 jobs and a fully integrated manufacturing hub.

Researchers from UNSW and Trina Solar developed a silver-free silicon tunnel-back-contact solar cell using dual-polarity ...

A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...

Deep beneath the icy waters surrounding Antarctica, a small marine organism may hold clues to a future cancer treatment.

(Siarhei_Fetisenkov/Creatas Video+/Getty Images Plus) An eagerly awaited and controversial clinical trial to 'wind back the ...

Cell therapy, often referred to as a form of regenerative medicine, uses living cells or cell-derived products to support the ...

Gilead Sciences Inc. (NASDAQ: GILD) is one of the top large cap value stocks to buy now. On June 8, Gilead Sciences and Merck ...

In a landmark achievement in biological imaging, researchers at Biohub and the University of California, Berkeley today announced the successful demonstration of the laser phase plate, a novel device ...